Cardiac Imaging: Page 109

Lantheus to proceed with flurpiridaz F-18 program
By AuntMinnie.com staff writers
Contrast agent developer Lantheus Medical Imaging plans to proceed with a phase III program for its flurpiridaz F-18 PET radiopharmaceutical, based on an interim analysis of data from its first phase III study.
April 30, 2013
Teleflex gets nod from FDA
By AuntMinnie.com staff writers
Medical device developer Teleflex announced that its Arrow VPS G4 device for catheter line placement has received 510(k) clearance from the U.S. Food and Drug Administration.
April 28, 2013
New heart failure imaging guidelines released
By AuntMinnie.com staff writers
New appropriateness criteria published by the American College of Cardiology Foundation and the American College of Radiology offer guidance on the use of cardiovascular imaging in heart failure patients, addressing several specific clinical scenarios.
April 28, 2013
US shows how air pollution speeds up atherosclerosis
By AuntMinnie.com staff writers
Ultrasound has revealed that long-term exposure to air pollution may lead to heart attacks and strokes by speeding up atherosclerosis, according to research published this week in PLOS Medicine.
April 24, 2013
Researchers launch library of 3D heart models
By AuntMinnie.com staff writers
Researchers from the University of Minnesota are using 3D computer models generated from contrast-enhanced CT studies to create a digital anatomical library of human heart specimens.
April 17, 2013
Postmortem MRI shows sudden cardiac death invisible at autopsy
By Eric Barnes
In results that add substantial forensic power to identifying the cause of death, postmortem cardiac 3-tesla MRI has been found to identify sudden cardiac death in cases that are invisible at conventional autopsy, according to new research published online in the Journal of the American College of Cardiology.
April 16, 2013
2013 04 16 14 22 01 684 Jackowski peracute 20130416213647
Ziehm, Mallinckrodt strike a deal
By AuntMinnie.com staff writers
C-arm developer Ziehm Imaging and contrast developer Mallinckrodt have announced a collaboration in which the firms are more closely integrating their products in the field of vascular surgery.
April 14, 2013
Boston Scientific places new MRI pacing system
By AuntMinnie.com staff writers
Interventional technology developer Boston Scientific announced it has implanted its ImageReady MR-conditional pacing system in the first patient enrolled in the ImageReady MR Conditional Pacing System Clinical Study at Ohio Health's Riverside Methodist Hospital in Columbus.
April 14, 2013
Advanced CT reconstruction improves cardiac plaque assessment
By Eric Barnes
Automated plaque assessment in coronary CT angiography is a promising new way to evaluate a patient's plaque burden quickly and noninvasively -- but it won't be quick or accurate without the use of advanced iterative reconstruction, according to researchers from Massachusetts General Hospital in Boston.
April 11, 2013
2013 04 11 16 25 51 400 2013 04 12 Puchner Thumb
Cell>Point touts cardiac imaging agent trial results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Cell>Point said that results from phase I and IIa studies of its technetium-99m-labeled ethylenedicysteine-glucosamine (99mTc-EC-G) nuclear imaging contrast agent have been favorable for evaluating the presence and severity of coronary artery disease.
April 9, 2013
ASE addresses TEE as part of Choosing Wisely
By AuntMinnie.com staff writers
The American Society of Echocardiography (ASE) has released a list of five interventions, including transesophageal echocardiography (TEE), that physicians and patients should discuss as part of the Choosing Wisely initiative.
April 3, 2013
Asia-Pacific interventional market primed for growth
By AuntMinnie.com staff writers
Spurred on by a steadily aging population and a high incidence of cardiovascular and cerebrovascular disease, the Asia-Pacific interventional radiology and cardiology market is projected to increase at a compound annual growth rate of 3.5% through 2017, said market research firm Frost & Sullivan.
March 27, 2013
Previous Page
Page 109 of 322
Next Page